Christina Christersson
Adjunct senior lecturer at Department of Medical Sciences; Cardiology
- Telephone:
- +46 18 611 90 68
- E-mail:
- Christina.Christersson@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Researcher at UCR-Uppsala Clinical Research center
- E-mail:
- christina.christersson@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Christina Christersson at UCR-Uppsala Clinical Research center
More information is available to staff who log in.
Publications
Selection of publications
- Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome (2023)
- Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography (2023)
- Pregnancy Complications and Risk of Cardiovascular Disease Later in Life (2022)
- Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation (2022)
- Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death (2021)
- Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma (2021)
- Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement (2020)
- Role of Extracellular Vesicles in Pulmonary Arterial Hypertension Modulation of Pulmonary Endothelial Function and Angiogenesis (2020)
- Changes in global longitudinal strain and left ventricular ejection fraction during the first year after myocardial infarction (2018)
- Microparticles during long-term follow-up after acute myocardial infarction (2017)
Recent publications
- Symptoms during pregnancy in primiparous women with congenital heart disease (2024)
- Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone (2024)
- Breastfeeding in primiparous women with congenital heart disease (2024)
- Self-rated health in primiparous women with congenital heart disease before, during and after pregnancy (2024)
- Time to childbirth and assisted reproductive treatment in women with congenital heart disease (2024)
All publications
Articles
- Symptoms during pregnancy in primiparous women with congenital heart disease (2024)
- Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone (2024)
- Breastfeeding in primiparous women with congenital heart disease (2024)
- Self-rated health in primiparous women with congenital heart disease before, during and after pregnancy (2024)
- Time to childbirth and assisted reproductive treatment in women with congenital heart disease (2024)
- Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation (2024)
- Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome (2023)
- Interaction of heart failure and stroke (2023)
- Transcatheter Intervention for Coarctation of the Aorta (2023)
- Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index (2023)
- Management of patients on antithrombotic therapy with severe infections (2023)
- Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction (2023)
- Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography (2023)
- Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation (2023)
- Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease (2022)
- Interventions in Adults With Repaired Coarctation of the Aorta (2022)
- Pregnancy Complications and Risk of Cardiovascular Disease Later in Life (2022)
- Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation (2022)
- A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function (2022)
- Spontaneous Coronary Artery Dissection and Papillary Muscle Rupture in Patient With Undiagnosed Vascular Ehler-Danlos Syndrome. (2022)
- Cause-Specific Mortality in Patients During Long-Term Follow-Up After Atrial Switch for Transposition of the Great Arteries (2022)
- MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response (2022)
- Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation (2022)
- Rationale, design and methodology of APPROACH-IS II (2022)
- Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH (2022)
- Does persistent (patent) foramen ovale closure reduce the risk of recurrent decompression sickness in scuba divers? (2021)
- Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II) (2021)
- Screening of biomarkers for prediction of multisite artery disease in patients with recent myocardial infarction (2021)
- Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death (2021)
- Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma (2021)
- High prevalence of ascending aortic dilation in adults with repaired coarctation of the aorta. (2021)
- Despite reductions in muscle mass and muscle strength in adults with CHD, the muscle strength per muscle mass relationship does not differ from controls (2021)
- Patients with complex congenital heart disease have slower calf muscle oxygenation during exercise (2021)
- Reply to "letter to the editor regarding 'low bone mineral density in adults with complex congenital heart disease'" (2021)
- Implantable cardiac devices in adult patients with repaired tetralogy of Fallot (2021)
- Exercise capacity in adult patients with tetralogy of Fallot (2021)
- Preoperative heart failure worsens outcome after aortic valve replacement irrespective of left ventricular ejection fraction. (2021)
- Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement (2020)
- Haemorrhagic stroke and major bleeding after intervention with biological aortic valve prosthesis (2020)
- Papillarmuskelruptur - en klinisk kameleont med hög mortalitet (2020)
- Role of Extracellular Vesicles in Pulmonary Arterial Hypertension Modulation of Pulmonary Endothelial Function and Angiogenesis (2020)
- Pregnancy and Aortic Dissection (2020)
- Low bone mineral density in adults with complex congenital heart disease (2020)
- Outpatient volumes and medical staf fing resources as predictors for continuity of follow-up care during transfer of adolescents with congenital heart disease (2020)
- Effect of medical treatment in patients with systemic right ventricle. (2020)
- Compared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF. (2020)
- Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial (2020)
- Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. (2019)
- Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease (2019)
- A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). (2019)
- Slower Skeletal Muscle Oxygenation Kinetics in Adults With Complex Congenital Heart Disease (2019)
- Sarcopenia is common in adults with complex congenital heart disease (2019)
- Factors associated with health-related quality of life among adults with tetralogy of Fallot (2019)
- Do self-reported pregnancy complications add to risk evaluation in older women with established cardiovascular disease? (2019)
- Changes in global longitudinal strain and left ventricular ejection fraction during the first year after myocardial infarction (2018)
- NOAK vid klaffsjukdom - (2018)
- Higher Preoperative Plasma Thrombin Potential in Patients Undergoing Surgery for Aortic Stenosis Compared to Surgery for Stable Coronary Artery Disease (2018)
- An Observational Study of the Occurence of Anxiety, Depression and self-reported Quality of Life 2 Years after Myocardial Infarction (2018)
- The year in cardiology 2017 (2018)
- Sensitive detection of platelet-derived and tissue factor positive extracellular vesicles in plasma using solid-phase proximity ligation assay (2018)
- Sensitive and Specific Detection of Platelet-Derived and Tissue Factor-Positive Extracellular Vesicles in Plasma using Solid-Phase Proximity Ligation Assay (2018)
- The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients (2017)
- Microparticles during long-term follow-up after acute myocardial infarction (2017)
- How to use D-dimer in acute cardiovascular care (2017)
- Poor blood pressure control in adults with repaired coarctation of the aorta and hypertension (2017)
- Usefulness of traditional echocardiographic parameters in assessment of left ventricular function in patients with normal ejection fraction early after acute myocardial infarction (2016)
- High incidence of infective endocarditis in adults with congenital ventricular septal defect (2016)
- The composition and daily variation of microparticles in whole blood in stable coronary artery disease (2016)
- Examining Female-Specific Factors Lends Insight Into Women's More Favorable Prognosis in Transcatheter Aortic Valve Replacement (2016)
- Sex-Specific Research (2016)
- Ankle brachial index most important to identify polyvascular disease in patients with non-ST elevation or ST-elevation myocardial infarction (2016)
- Left ventricular hypertrophy in adults with previous repair of coarctation of the aorta; association with systolic blood pressure in the high normal range (2016)
- Adults with repaired coarctation of the aorta (2016)
- Left ventricular hypertrophy in adults with previous repair of coarctation of the aorta (2016)
- Hypertension in adults with repaired coarctation of the aorta (2016)
- Catheter closure of atrial septal defect in the elderly (>= 65 years) (2016)
- Circulating cell-derived microparticles as biomarkers in cardiovascular disease (2016)
- How frequent are signs of left ventricular dysfunction in acute myocardial infarction patients with normal ejection fraction? (2015)
- High incidence of endocarditis in adults with congenital ventricular septal defect (2015)
- The change of the amount of circulating microparticles and their association to the general atherosclerotic burden after acute coronary syndrome (2015)
- Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease (2015)
- Design and rationale of TROCADERO (2015)
- Height, weight and body mass index in adults with congenital heart disease (2015)
- MiR-223-3p post-transcriptionally regulates the expression of F3, the human tissue factor gene, and TF expression in acute coronary syndrome (2015)
- Atrial septal defect device closure in the elderly, symptomatic benefits except for arrhythmia (2015)
- Assessing disease-specific patient reported outcomes within the Swedish National Quality Register AURICULA (2015)
- D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation (2014)
- The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment (2014)
- Evaluation of microparticles in whole blood by multicolour flow cytometry assay (2013)
- N-Terminal Pro-B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation (2013)
- Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation (2013)
- A Randomized Trial of Genotype-Guided Dosing of Warfarin (2013)
- Increased levels of D-dimer in atrial fibrillation identify patients with higher risk of thromboembolic events and death (2012)
- Increased levels of D-dimer identify patients with atrial fibrillation at high risk for bleeding an ARISTOTLE substudy (2012)
- High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin (2012)
- NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin (2012)
- Treatment with an Oral Direct Thrombin Inhibitor Decreases Platelet Activity but Increases Markers of Inflammation in Patients with Myocardial Infarction. (2011)
- The Influence of Direct Thrombin Inhibitors on the Formation of Platelet-leukocyte Aggregates and Tissue Factor Expression (2010)
- Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10 (2008)
- Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events (2007)
- Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischemic events (2007)
- Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction (2005)
- Biomarkers in addition to clinical characteristics for prediction of peripheral artery disease in patients with recent myocardial infarction
- Biochemical biomarkers associated with peripheral artery disease contribute to prediction of outcome during long-term follow up after myocardial infarction
- Biomarkers for cardiovascular disease in women with spontaneous preterm birth – A case control study
- Pregnancy complications in women with structural heart disease and long-term risk of cardiovascular events
Books
Conferences
- How the echocardiographic parameters of left ventricular function change during the first year after myocardial infarction when the ejection fraction remains normal? (2015)
- How common is systolic left ventricular dysfunction in patients with acute myocardial infarction when ejection fraction remains preserved? Impact of the latest chamber quantification recommendations. (2015)
- Which indexes of left ventricular systolic dysfunction are best to reflect the size of myocardial infarction even if ejection fraction is normal? (2014)
- The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment (2014)
